Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00304785Phase 4Completed
A Phase 4 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by PRN Pharmaceutical Research Network. Started May 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00304785.